(2022). . , 77(6), 2385-2393. doi: 10.22092/ari.2022.358614.2264
. "". , 77, 6, 2022, 2385-2393. doi: 10.22092/ari.2022.358614.2264
(2022). '', , 77(6), pp. 2385-2393. doi: 10.22092/ari.2022.358614.2264
. , 2022; 77(6): 2385-2393. doi: 10.22092/ari.2022.358614.2264

Archives of Razi Institute
Article 46, Volume 77, Issue 6, January and February 0, Pages 2385-2393    PDF (709.98 K)
Document Type: مقالات پژوهشی
DOI: 10.22092/ari.2022.358614.2264
Supplementary Files
References
  1. Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol. 2014;2(6):645-8.
  2. Dunn R, Busse P, Wechsler M. Asthma in the elderly and late‐onset adult asthma. Allergy. 2018;73(2):284-94.
  3. Wang YC, Jaakkola M, Lajunen T, Lai CH, Jaakkola J. Asthma‐COPD overlap syndrome among subjects with newly diagnosed adult‐onset asthma. Allergy. 2018;73(7):1554-7.
  4. Eiwegger T, Soyka MB, Leung DY, Akdis CA, Bacharier L, Cunningham-Rundles C. Allergic Rhinitis. Pediatric Allergy, E-Book: Principles and Practice. 2020;135.
  5. Campo P, Eguiluz‐Gracia I, Bogas G, Salas M, Plaza Serón C, Pérez N, et al. Local allergic rhinitis: implications for management. Clin Exp Allergy. 2019;49(1):6-16.
  6. Davraj K, Yadav M, Chappity P, Sharma P, Grover M, Sharma S, et al. Nasal Physiology and Sinusitis. Essentials of Rhinology: Springer; 2021. p. 49-101.
  7. Satyaraj E, Wedner HJ, Bousquet J. Keep the cat, change the care pathway: a transformational approach to managing Fel d 1, the major cat allergen. Allergy. 2019;74:5-17.
  8. Pothirat C, Chaiwong W. A Real-World Effectiveness of Subcutaneous Immunotherapy on the Cost of Medication, Allergic Rhinitis, and Asthma Exacerbations, as well as Upper Respiratory Tract Infection in Subjects with Allergic Rhinitis with or without Asthma: A Retrospective Pilot Study. Medicina. 2021;57(11):1229.
  9. Ferreira LKP, Ferreira LAP, Monteiro TM, Bezerra GC, Bernardo LR, Piuvezam MR. Combined allergic rhinitis and asthma syndrome (CARAS). Int Immunopharmacol. 2019;74:105718.
  10. Naafs M. The burden of allergic rhinitis: a mini-review. Glob J Oto. 2018;13(1):555854.
  11. Eddy RL. Structure and Function of Asthma Evaluated Using Pulmonary Imaging. 2020.
  12. Wang C, Liu Y, Zhu Y, Kong C. Functions of mammalian SIRT4 in cellular metabolism and research progress in human cancer. Oncol Lett. 2020;20(4):1.
  13. Boskabady MH, Amin F, Shakeri F. The effect of Curcuma longa on inflammatory mediators and immunological, oxidant, and antioxidant biomarkers in asthmatic rats. Evid-Based Complement Altern Med. 2021;2021.
  14. Ito JT, Lourenço JD, Righetti RF, Tibério IF, Prado CM, Lopes FD. Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies? Cells. 2019;8(4):342.
  15. Matucci A, Vultaggio A, Maggi E, Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res. 2018;19(1):1-10.
  16. Krynytska I, Kucher S, Tokarskyy O, Koval M. The association of angiotensin-converting enzyme gene insertion/deletion polymorphism with bronchial asthma. Pol Merkur Lekarski. 2021;49(294):391-3.
  17. Lee L-Y, Hew GSY, Mehta M, Shukla SD, Satija S, Khurana N, et al. Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sci. 2021;267:118973.
  18. Nakagome K, Nagata M. Involvement and possible role of eosinophils in asthma exacerbation. Front Immunol. 2018:2220.
  19. Zhong L, Simard MJ, Huot J. Endothelial microRNAs regulating the NF‐κB pathway and cell adhesion molecules during inflammation. FASEB J. 2018;32(8):4070-84.
  20. Menzella F, Ghidoni G, Galeone C, Capobelli S, Scelfo C, Facciolongo NC. Immunological aspects related to viral infections in severe asthma and the role of omalizumab. Biomedicines. 2021;9(4):348.
  21. Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355-62.
  22. Robertson TF, Huttenlocher A. Real‐time imaging of inflammation and its resolution: It’s apparent because it’s transparent. Immunol Rev. 2022.
  23. Shao S, Fang H, Dang E, Xue K, Zhang J, Li B, et al. Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4/IL-36R crosstalk. Front Immunol. 2019;10:746.
  24. De Bondt M, Hellings N, Opdenakker G, Struyf S. Neutrophils: underestimated players in the pathogenesis of Multiple Sclerosis (MS). Int J Mol Sci. 2020;21(12):4558.
  25. Kienle K, Glaser KM, Eickhoff S, Mihlan M, Knöpper K, Reátegui E, et al. Neutrophils self-limit swarming to contain bacterial growth in vivo. Science. 2021;372(6548):eabe7729.
  26. Wu Y, Li W, Hu Y, Liu Y, Sun X. Suppression of sirtuin 1 alleviates airway inflammation through mTOR‑mediated autophagy. Mol Med Rep. 2020;22(3):2219-26.
  27. Hui B, Hou X, Liu R, Liu X-H, Hu Z. Gypenoside inhibits ox-LDL uptake and foam cell formation through enhancing Sirt1-FOXO1 mediated autophagy flux restoration. Life Sci. 2021;264:118721.
  28. Shi Z, Sun Y, Wang K, Jia J, Yang J, Li Y. Effects of miR-26a/miR-146a/miR-31 on airway inflammation of asthma mice and asthma children. Eur Rev Med Pharmacol Sci. 2019;23(12):5432-40.
  29. Cheng L, Chen J, Fu Q, He S, Li H, Liu Z, et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2018;10(4):300-53.
  30. Chen M, Chen Z, Huang D, Sun C, Xie J, Chen T, et al. Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway. Pulm Pharmacol Ther. 2020;65:102000.
  31. Kytikova OY, Perelman JM, Novgorodtseva TP, Denisenko YK, Kolosov VP, Antonyuk MV, et al. Peroxisome proliferator-activated receptors as a therapeutic target in asthma. PPAR Res. 2020;2020.
  32. Lei H, Sun Y, Quan S. IL‑37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis. Exp Ther Med. 2020;20(4):3114-21.
  33. Branicka O, Jura-Szołtys E, Rogala B, Glück J. Elevated serum level of CD48 in patients with intermittent allergic rhinitis. Int Arch Allergy Immunol. 2021;182(1):39-48.
  1. Sun Z, Vattepu R, Zhang S. Chemokines and Innate Lymphoid Cells in Skin Inflammation. Cells. 2021;10(11):3074.
  2. Rouadi PW, Idriss SA, Naclerio RM, Peden DB, Ansotegui IJ, Canonica GW, et al. Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD). World Allergy Organ J. 2020;13(10):100467.
  3. Gökkaya M, Damialis A, Nussbaumer T, Beck I, Bounas-Pyrros N, Bezold S, et al. Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure. J Allergy Clin Immunol. 2020;146(3):583-94.
  4. Berghi NO, Dumitru M, Vrinceanu D, Ciuluvica RC, Simioniuc-Petrescu A, Caragheorgheopol R, et al. Relationship between chemokines and T lymphocytes in the context of respiratory allergies. Exp Ther Med. 2020;20(3):2352-60.
  1. Iype J, Fux M. Basophils Orchestrating Eosinophils’ Chemotaxis and Function in Allergic Inflammation. Cells. 2021;10(4):895.
  2. Khan MA, Alam Q, Haque A, Ashafaq M, Khan MJ, Ashraf GM, et al. Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: an update. Curr Neuropharmacol. 2019;17(3):232-46.
  3. Ong AL, Ramasamy TS. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018;43:64-80.
  4. Ren X, Wang Z. High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis. Life Sci. 2021;271:119218.
  5. Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA, editors. Immunologic mechanisms in asthma. Seminars in immunology; 2019: Elsevier.
Statistics
Article View: 15,609
PDF Download: 57,414


counter
Journal management system. designed by sinaweb